The Untapped Potential of Genetically Engineered Mouse Models in Chemoprevention Research: Opportunities and Challenges

被引:19
作者
Abate-Shen, Cory [1 ]
Brown, Powel H. [3 ,4 ]
Colburn, Nancy H. [5 ]
Gerner, Eugene W. [6 ]
Green, Jeffery E. [7 ]
Lipkin, Martin [2 ]
Nelson, William G. [8 ]
Threadgill, David [9 ,10 ]
机构
[1] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10032 USA
[2] Cornell Univ, Weill Med Coll, Strang Canc Prevent Ctr, New York, NY 10021 USA
[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[5] NCI, Lab Canc Prevent, Frederick, MD 21701 USA
[6] Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ USA
[7] NCI, Canc Biol Lab, Bethesda, MD 20892 USA
[8] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
[9] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
10.1158/1940-6207.CAPR-08-0076
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The past decade has witnessed the unveiling of a powerful new generation of genetically engineered mouse ( GEM) models of human cancer, which are proving to be highly effective for elucidating cancer mechanisms and interrogating novel experimental therapeutics. This new generation of GEM models are well suited for chemoprevention research, particularly for investigating progressive stages of carcinogenesis, identifying biomarkers for early detection and intervention, and preclinical assessment of novel agents or combinations of agents. Here we discuss opportunities and challenges for the application of GEM models in prevention research, as well as strategies to maximize their relevance for human cancer.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 46 条
[1]
Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice [J].
Branda, CS ;
Dymecki, SM .
DEVELOPMENTAL CELL, 2004, 6 (01) :7-28
[2]
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[3]
Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[4]
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors [J].
Dankort, David ;
Filenova, Elena ;
Collado, Manuel ;
Serrano, Manuel ;
Jones, Kirk ;
McMahon, Martin .
GENES & DEVELOPMENT, 2007, 21 (04) :379-384
[5]
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression [J].
DeNardo, David G. ;
Coussens, Lisa M. .
BREAST CANCER RESEARCH, 2007, 9 (04)
[6]
Tissue-specific and reversible RNA interference in transgenic mice [J].
Dickins, Ross A. ;
McJunkin, Katherine ;
Hernando, Eva ;
Premsrirut, Prem K. ;
Krizhanovsky, Valery ;
Burgess, Darren J. ;
Kim, Sang Yong ;
Cordon-Cardo, Carlos ;
Zender, Lars ;
Hannon, Gregory J. ;
Lowe, Scott W. .
NATURE GENETICS, 2007, 39 (07) :914-921
[7]
Dove WF, 1997, CANCER RES, V57, P812
[8]
A mouse to human search for plasma Proteome changes associated with pancreatic tumor development [J].
Faca, Vitor M. ;
Song, Kenneth S. ;
Wang, Hong ;
Zhang, Qing ;
Krasnoselsky, Alexei L. ;
Newcomb, Lisa F. ;
Plentz, Ruben R. ;
Gurumurthy, Sushma ;
Redston, Mark S. ;
Pitteri, Sharon J. ;
Pereira-Faca, Sandra R. ;
Ireton, Renee C. ;
Katayama, Hiroyuki ;
Glukhova, Veronika ;
Phanstiel, Douglas ;
Brenner, Dean E. ;
Anderson, Michelle A. ;
Misek, David ;
Scholler, Nathalie ;
Urban, Nicole D. ;
Barnett, Matt J. ;
Edelstein, Cim ;
Goodman, Gary E. ;
Thornquist, Mark D. ;
McIntosh, Martin W. ;
DePinho, Ronald A. ;
Bardeesy, Nabeel ;
Hanash, Samir M. .
PLOS MEDICINE, 2008, 5 (06) :953-967
[9]
Reversible tumorigenesis by MYC in hematopoietic lineages [J].
Felsher, DW ;
Bishop, JM .
MOLECULAR CELL, 1999, 4 (02) :199-207
[10]
Development of a flexible and specific gene delivery system for production of murine tumor models [J].
Fisher, GH ;
Orsulic, S ;
Holland, E ;
Hively, WP ;
Li, Y ;
Lewis, BC ;
Williams, BO ;
Varmus, HE .
ONCOGENE, 1999, 18 (38) :5253-5260